Stocks / NASDAQ / Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

Our Opinion

Lexicon Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“These results from human genetic studies further support Lexicon’s therapeutic strategy based on original observations made using animal models.” Read the following article

Company Description

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. [Source: MarketWatch]

Company Website: